minimally invasive surgical instruments
Search documents
Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial Expansion
Prnewswire· 2025-12-03 13:30
NEW YORK,Dec. 3, 2025/PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ:[BDMD](#financial-modal)) ("Baird Medical" or the "Company"), a market leader in minimally invasive Microwave Ablation (MWA) technology, today announced the appointment of Mark Saxton as Chief Executive Officer of its U.S. subsidiary.Mr. Saxton is a seasoned medical device executive with more than 25 years of commercial leadership experience, including a decade advancing intravascular RF ablation technologies. He will lead a ...
Baird Medical to Participate in the AAES 2025 Annual Meeting
Prnewswire· 2025-05-06 12:30
Core Insights - The AAES Annual Meeting is a key event for endocrine surgeons in North America, focusing on advancements in endocrine surgery, particularly in thyroid diseases, parathyroid, adrenal glands, and endocrine pancreas [1] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatment, focusing on surgical robotic systems and innovative surgical instruments [5] - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics across the United States, including Johns Hopkins Hospital and Columbia University Medical Center [5] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its commercial presence in over 20 countries worldwide [5] Strategic Engagement - Baird Medical's participation in the AAES 2025 meeting emphasizes the importance of its MWA technology in minimally invasive treatments for endocrine conditions, especially thyroid nodules [2] - The company views the meeting as an opportunity to gain insights into surgical advancements and clinical trends, supporting its strategic initiatives and fostering collaborations [3] - Baird Medical aims to contribute to scientific exchange and advance patient care through technological innovation at the 2025 meeting in Milwaukee [4]
Baird Medical to Participate in COSM 2025 Conference
Prnewswire· 2025-05-05 12:30
Core Insights - Baird Medical is participating in the COSM conference, which is a significant event for the otolaryngology community, aimed at advancing research and clinical education in head and neck surgery [1][2] Company Overview - Baird Medical specializes in minimally invasive diagnostics and treatments, focusing on surgical robotic systems and innovative surgical instruments [4] - The company is FDA 510(k)-certified and its solutions are utilized in over 30 prestigious hospitals and clinics in the United States, including Johns Hopkins Hospital and Columbia University Medical Center [4] - Baird Medical is a market leader in China for thyroid microwave ablation devices and is expanding its presence in over 20 countries worldwide [4] Strategic Engagement - The participation in COSM allows Baird Medical to engage with key opinion leaders, clinicians, and researchers, showcasing its portfolio of minimally invasive solutions [2][3] - The company aims to collaborate with healthcare professionals to explore innovative approaches and integrated care strategies to improve patient outcomes in otolaryngology [3]